Compare CNVS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNVS | BTMD |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.1M | 64.4M |
| IPO Year | 2016 | 2021 |
| Metric | CNVS | BTMD |
|---|---|---|
| Price | $3.10 | $2.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $9.00 | $6.00 |
| AVG Volume (30 Days) | ★ 434.7K | 141.9K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.99 | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | $78,181,000.00 | ★ $197,191,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.92 | $2.37 |
| P/E Ratio | ★ N/A | $3.12 |
| Revenue Growth | ★ 59.13 | 6.38 |
| 52 Week Low | $1.77 | $2.02 |
| 52 Week High | $7.39 | $4.75 |
| Indicator | CNVS | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.72 | 47.97 |
| Support Level | $2.47 | $2.02 |
| Resistance Level | $3.49 | $2.37 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 79.65 | 52.47 |
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.